Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Patrick J. Tchou, MD, is Associate Section Head of the Section of Electrophysiology and Cardiac Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. He is Co-Director of the Ventricular Arrhythmia Center and is a practicing Staff Physician concentrating on treatment of cardiac arrhythmias, especially those of complex origins.
Dr. Tchou is board-certified in internal medicine and cardiovascular disease, with added qualification in clinical cardiac electrophysiology. He is a fellow of the American College of Cardiology and serves as a reviewer for numerous scientific publications including Circulation, the Journal of the American College of Cardiology and Pacing and Cardiac Electrophysiology.
Dr. Tchou has authored and co-authored hundreds of abstracts and articles on different aspects of electrophysiology for scientific publications. Dr. Tchou also has authored and co-authored a number of chapters for cardiovascular textbooks. His research interests include sudden cardiac death and percutaneous catheter ablation of cardiac arrhythmias.
A graduate of the Case Western Reserve University School of Medicine, Dr. Tchou completed his internal medicine residency and his cardiology fellowship at Cleveland Metropolitan General Hospital. He completed a fellowship in cardiac electrophysiology at the University of Wisconsin's Sinai Samaritan Medical Center in Milwaukee.
In 1986, Dr. Tchou received the Young Investigator's Award from the North American Society of Pacing and Electrophysiology. He was the Director of the Cardiac Electrophysiology Laboratory at Sinai Samaritan Medical Center in Milwaukee from 1987 to 1990. In 1990, he assumed the position of Director, Section of Cardiac Electrophysiology, at University of Pittsburgh Medical Center. In 1994, he returned to Cleveland to join Cleveland Clinic.
He has been an innovative practitioner of catheter ablation from its inception in the early 1980s and continues to enjoy the challenges of treating cardiac arrhythmias.
Abnormal Heart Rhythms, Long QT Syndrome, Atrial Fibrillation, Supraventricular Tachycardia, Ventricular Tachycardia, wolff-Parkinson-White Syndrome, Biventricular Pacemaker, Catheter Ablation, Implantable Cardioverter Defibrillator, Pacemaker Implant, Pulmonary Vein Isolation Ablation
Awards & Honors
Best Doctors in America, since 1994
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/9/2013, Dr. Tchou has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.